André Chollet Selected Research

Mifepristone (RU 486)

6/2007

Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

André Chollet Research Topics

Disease

4	Premature Obstetric Labor (Premature Labor) 01/2018 - 06/2007
2	Inflammation (Inflammations) 01/2019 - 09/2002
1	Breast Neoplasms (Breast Cancer) 11/2017
1	Body Weight (Weight, Body) 04/2016
1	Pneumonia (Pneumonitis) 08/2011
1	Premature Birth (Birth, Premature) 06/2007
1	Rupture 06/2007

Drug/Important Bio-Agent (IBA)

2	prostaglandin F2alpha receptorIBA 07/2007 - 06/2007
1	atosibanIBA 01/2019
1	nolasibanIBA 01/2019
1	ProstaglandinsIBA 01/2018
1	obe022IBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	Oxytocin Receptors (Oxytocin Receptor)IBA 04/2016
1	acivicin (AT 125)IBA 04/2016
1	OBE001IBA 04/2016
1	OvalbuminIBA 08/2011
1	AS604872IBA 06/2007
1	Progestins (Progestagens)IBA 06/2007
1	Prostaglandin Receptors (Prostaglandin Receptor)IBA 06/2007
1	Tocolytic Agents (Tocolytics)IBA 06/2007
1	DinoprostIBA 06/2007
1	Mifepristone (RU 486)FDA Link 06/2007
1	Peptides (Polypeptides)IBA 09/2002
1	LigandsIBA 09/2002
1	GTP-Binding Proteins (G-Protein)IBA 09/2002
1	Chemokine ReceptorsIBA 09/2002
1	CCR ReceptorsIBA 09/2002

Therapy/Procedure

1	Mastectomy (Mammectomy) 11/2017
1	Cesarean Section (Caesarean Section) 04/2016
1	Tocolysis 06/2007